Impact of Bicytopenia on Mortality in Hospitalised Patients With Heart Failure
References
- Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90. DOI: 10.1161/CIRCULATIONAHA.116.021884
- Malcovati L, Cazzola M. The shadowlands of MDS: Idiopathic cytopenias of undetermined significance (ICUS) and clonal hematopoiesis of indeterminate potential (CHIP). Hematology American Society of Hematology Education Program. 2015;2015:299–307. DOI: 10.1182/asheducation-2015.1.299
- Rahman EU, Chobufo MD, Farah F, Mohamed T, Elhamdani M, Rueda C, et al. Prevalence and temporal trends of anemia in patients with heart failure. QJM. 2022;115(7):437–441. DOI: 10.1093/qjmed/hcab193
- Chopra VK, Anker SD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. ESC Heart Failure. 2020;7(5):2007–2011. DOI: 10.1002/ehf2.12797
- van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: Mechanisms and therapeutic approaches. Nature Reviews Cardiology. 2011;8(9):485–493. DOI: 10.1038/nrcardio.2011.77
- Anand I, McMurray JJ, Whitmore J, Warren M, Pham A, McCamish MA, et al. Anemia and its relationship to clinical outcome in heart failure. Circulation. 2004;110(2):149–154. DOI: 10.1161/01.CIR.0000134279.79571.73
- Hakuno D, Fukae T, Takahashi M, Takiguchi S, Li HC, Nishizawa K, et al. Combinations of cardiac and non-cardiac predictors for prognoses in patients with acute heart failure. European Heart Journal: Quality of Care and Clinical Outcomes. 2021;7(1):83–96. DOI: 10.1093/ehjqcco/qcz059
- Marvasti TB, Alibhai FJ, Yang GJ, Li SH, Wu J, Yau T, et al. Heart failure impairs bone marrow hematopoietic stem cell function and responses to injury. Journal of American Heart Association. 2023;12(11):
e027727 . DOI: 10.1161/JAHA.122.027727 - Singh A, Hungund B, Kumar L, Pattanshetti M. Clinico-haematological profile of patients with bicytopenia. Pathology. 2018;50(5):540–548. DOI: 10.1016/j.pathol.2018.03.008
- World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. [Cited 2025 Jan 3]. Available from:
https://iris.who.int/bitstream/handle/10665/85839/WHO_NMH_NHD_MNM_11.1_eng.pdf?sequence=22 . - Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. European Journal of Heart Failure. 2021;23(3):352–380. DOI: 10.1002/ejhf.2115
- McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. New England Journal of Medicine. 1971;285(26):1441–1446. DOI: 10.1056/NEJM197112232852601
- Mui JV, Zhou J, Lee S, Leung KSK, Lee TTL, Chou OHI, et al. Sodium-glucose cotransporter 2(SGLT2) inhibitors vs. dipeptidyl peptidase-4(DPP4) inhibitors for new-onset dementia: a propensity score-matched population-based study with competing risk analysis. Frontiers of Cardiovascular Medicine. 2021;8:
747620 . DOI: 10.3389/fcvm.2021.747620 - Kwok B, Hall JM, Witte JS, Xu Y, Reddy P, Lin K, et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 2015;126(21):2355–2361. DOI: 10.1182/blood-2015-08-667063
- Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, et al. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017;21(3):374–382.e4. DOI: 10.1016/j.stem.2017.07.010
- Vicente-Ibarra N, Marín F, Pernías-Escrig V, Sandín-Rollán M, Núñez-Martínez L, Lozano T, et al. Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome. European Journal of Internal Medicine. 2019;61:48–53. DOI: 10.1016/j.ejim.2018.12.004
- Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Critical Care Medicine. 2002;30(8):1765–1771. DOI: 10.1097/00003246-200208000-00015
- Vlasschaert C, Akwo E, Robinson-Cohen C, Cook EK, Lanktree MB, Rauh MJ, et al. Infection risk associated with clonal hematopoiesis of indeterminate potential is partly mediated by hematologic cancer transformation in the UK Biobank. Leukemia. 2023;37(11):2306–2308. DOI: 10.1038/s41375-023-02023-7
- Gupta K, Kalra R, Rajapreyar I, Joly JM, Pate M, Cribbs MG, et al. Anemia, mortality, and hospitalizations in heart failure with a preserved ejection fraction (from the TOPCAT Trial). The American Journal of Cardiology. 2020;125(9):1347–1354. DOI: 10.1016/j.amjcard.2020.01.046
- Mentz RJ, Greene SJ, Ambrosy AP, Vaduganathan M, Subacius HP, Swedberg K, et al. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circulation: Heart Failure. 2014;7(3):401–408. DOI: 10.1161/CIRCHEARTFAILURE.113.000840
- Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, et al. Etiology of anemia in patients with advanced heart failure. Journal of the American College of Cardiology. 2006;48(12):2485–2489. DOI: 10.1016/j.jacc.2006.08.034
- Gnanaraj J, Parnes A, Francis CW, Go RS, Takemoto CM, Hashmi SK. Approach to pancytopenia: Diagnostic algorithm for clinical hematologists. Blood Review. 2018;32(5):361–367. DOI: 10.1016/j.blre.2018.03.001
- Tahir N, Ashraf A, Waqar SHB, Rafae A, Kantamneni L, Sheikh T, et al. Copper deficiency, a rare but correctable cause of pancytopenia: A review of literature. Expert Review of Hematology. 2022;15(11):999–1008. DOI: 10.1080/17474086.2022.2142113
- Andrès E, Affenberger S, Zimmer J, Vinzio S, Grosu D, Pistol G, et al. Current hematological findings in cobalamin deficiency. a study of 201 consecutive patients with documented cobalamin deficiency. Clinical & Laboratory Haematology. 2006;28(1):50–56. DOI: 10.1111/j.1365-2257.2006.00755.x
- Lv S, Ru S. The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis. PLoS One. 2021;16(10):
e0259300 . DOI: 10.1371/journal.pone.0259300 - Packer M, Anker SD, Butler J, Cleland JGF, Kalra PR, Mentz RJ, et al. Redefining iron deficiency in patients with chronic heart failure. Circulation. 2024;150(2):151–161. DOI: 10.1161/CIRCULATIONAHA.124.068883
- Iversen PO, Woldbaek PR, Tønnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. American Journal of Physiology-Regulatory Integrative and Comparative Physiology. 2002;282(1):R166–R172. DOI: 10.1152/ajpregu.2002.282.1.R166
- Afan AM, Broome CS, Nicholls SE, Whetton AD, Miyan JA. Bone marrow innervation regulates cellular retention in the murine haemopoietic system. British Journal of Haematology. 1997;98(3):569–577. DOI: 10.1046/j.1365-2141.1997.2733092.x
- Zubcevic J, Jun JY, Kim S, Perez PD, Afzal A, Shan Z, et al. Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat. Hypertension. 2014;63(3):542–550. DOI: 10.1161/HYPERTENSIONAHA.113.02722
- Bazeley P, Morales R, Tang WHW. Evidence of clonal hematopoiesis and risk of heart failure. Current Heart Failure Reports. 2020;17(5):271–276. DOI: 10.1007/s11897-020-00476-w
- Yu B, Roberts MB, Raffield LM, Zekavat SM, Nguyen NQH, Biggs ML, et al. National Heart, Lung, and Blood Institute TOPMed Consortium. Supplemental association of clonal hematopoiesis with incident heart failure. Journal of American College of Cardiology. 2021;78(1):42–52. DOI: 10.1016/j.jacc.2021.04.085
- Svensson EC, Madar A, Campbell CD, He Y, Sultan M, Healey ML, et al. TET2-driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial. JAMA Cardiology. 2022;7(5):521–528. DOI: 10.1001/jamacardio.2022.0386
DOI: https://doi.org/10.5334/gh.1425 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jan 29, 2025
Accepted on: Apr 14, 2025
Published on: Apr 30, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Toshitaka Okabe, Tadayuki Yakushiji, Daiki Kato, Hirotoshi Sato, Toshihiko Matsuda, Yui Koyanagi, Katsuya Yoshihiro, Takeshi Okura, Yuma Gibo, Yuki Ito, Tatsuki Fujioka, Shigehiro Ishigaki, Shuro Narui, Taro Kimura, Suguru Shimazu, Yuji Oyama, Naoei Isomura, Masahiko Ochiai, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.